The role of NO synthases and especially iNOS is elegantly dissected by the work of Cotton et al., which proposes an active role of iNOS-induced NO production in endothelial cell damage and advances the concept of iNOS inhibition as a viable therapeutic strategy for SSc (14). The gene discussed is NOS2; the disease is systemic sclerosis.